Team NCPERE. Vital surveillances: the epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID—19)—China. China CDC Weekly2020; 2: 113–122.
2.
WuZMcGooganJM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China. JAMA Epub ahead of print 24February2020. Doi: 10.1001/jama.2020.2648.
3.
WangDHuBHuC, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA2020; 323: 1061–1069.
4.
MacLarenGFisherDBrodieD. Preparing for the most critically ill patients with COVID-19. The potential role of extracorporeal membrane oxygenation. JAMA. Epub ahead of print 19February2020. Doi: 10.1001/jama.2020.2342.
5.
ChenNZhouMDongX, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet2020; 395: 507–513.
6.
Novel Coronavirus Pneumonia Emergency Response Epidemiology Teamexternal iconexternal icon. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China. Zhonghua Liu Xing Bing Xue Za Zhi2020; 41: 145–151.
7.
BrodieDBacchettaM. Extracorporeal membrane oxygenation for ARDS in adults. N Engl J Med2011; 365: 1905–1914.
8.
RamanathanKAntogniniDCombesA, et al. Planning and provision of ECMO services for severe ARDS during the COVID-19 pandemic and other outbreaks of emerging infectious diseases. Lancet Respir Med2020; 8: 518–526.
9.
DaviesAJonesDBaileyM, et al. Extracorporeal membrane oxygenation for 2009 Influenza A(H1N1) acute respiratory distress syndrome. JAMA2009; 302: 1888–1895.
10.
ZangrilloABiondi-ZoccaiGLandoniG, et al. Extracorporeal membrane oxygenation (ECMO) in patients with H1N1 influenza infection: a systematic review and meta-analysis including 8 studies and 266 patients receiving ECMO. Crit Care2013; 17: R30.
11.
ArabiYMAl-OmariAMandourahY, et al. Critically ill patients with the Middle East respiratory syndrome: a multicenter retrospective cohort study. Crit Care Med2017; 45: 1683–1695.
12.
AlshahraniMSSindiAAlshamsiF, et al. Extracorporeal membrane oxygenation for severe Middle East respiratory syndrome coronavirus. Ann Intensive Care2018; 8: 3.
13.
LiXGuoZLiB, et al. Extracorporeal membrane oxygenation for coronavirus disease 2019 in Shanghai, China. ASAIO J2020; 66: 475–481.
14.
RuanQYangKWangW, et al. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med2020; 46: 846–848.
15.
JacobsJPStammersAHSt LouisJ, et al. Extracorporeal membrane oxygenation in the treatment of severe pulmonary and cardiac compromise in COVID-19: experience with 32 patients. ASAIO J. Epub ahead of print 17April2020. Doi:10.1097/MAT.0000000000001185.
16.
HenryBMLippiG. survival with extracorporeal membrane oxygenation in acute respiratory distress syndrome (ARDS) due to coronavirus disease 2019 (COVID-19): pooled analysis of early reports. J Crit Care2020; 58: 27–28.
HenryB. COVID-19, ECMO, and lymphopenia: a word of caution. Lancet Respir Med2020; 8: e24.
19.
WuCChenXCaiY, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med2020; e200994.
20.
RisnesIWagnerKUelandT, et al. Interleukin-6 may predict survival in extracorporeal membrane oxygenation treatment. Perfusion2008; 23: 173–178.
21.
World Health Organization. Clinical management of severe acute respiratory infection when novel coronavirus (2019-nCoV) infection is suspected—interim guidance, https://apps.who.int/iris/handle/10665/330893, 2020.
22.
BartlettRHOginoMTBrodieD, et al. Initial ELSO guidance document: ECMO for COVID-19 patients with severe cardiopulmonary failure. ASAIO J2020; 66: 472–474.
23.
CombesAHajageDCapellierG, et al. Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome. N Engl J Med2018; 378: 1965–1975.
24.
AlhazzaniWHylander MøllerMArabiYM, et al. Surviving sepsis campaign: guidelines on the management of critically ill adults with coronavirus disease 2019(COVID-19). Crit Care Med2020; 48: e440–e469.
25.
MatthayMAAldrichJMGottsJE. Treatment for severe acute respiratory distress syndrome from COVID-19. Lancet Respir Med2020; 8: 433–434.
26.
PravdaNSPravdaMSKornowskiR12, et al. Extracorporeal membrane oxygenation therapy in the COVID-19 pandemic. Future Cardiol. Epub ahead of print 17April2020. DOI: 10.2217/fca-2020-0040.
27.
ZochiosVBrodieDCharlesworthM, et al. Delivering extracorporeal membrane oxygenation for patients with COVID-19: what, who, when and how?Anaesthesia. Epub ahead of print 22April2020 Doi: 10.1111/anae.15099.
